We read with interest the recent paper by Peverill et al. [1] concerning the effects of percutaneous balloon mitral valvuloplasty (PBMV) on levels of prothrombin fragment 1j2 (F1j2) in mitral stenosis. They report that, overall, venous F1j2 levels increased, whereas atrial levels did not change after PBMV. With subgroup analyses, however, venous levels of F1j2 were significantly increased and left atrial levels decreased in the subgroup of 15 patients with increased regional left atrial thrombin generation, whereas both venous and left atrial F1j2 levels increased in the 22 patients with normal left atrial thrombin generation [1] .
mia has been associated with a hypercoagulable state, with abnormalities of haemostasis, platelets and endothelial dysfunction, which are independent of aetiology and underlying structural heart disease, and are altered by antithrombotic therapy and cardioversion [3] . We were pleased to note that Peverill et al. [1] only found a reduction in left atrial F1j2 levels in the patients with increased regional left atrial thrombin generation who were in sinus rhythm, and not among the patients who were in atrial fibrillation, which is in keeping with the highly prothrombotic or hypercoagulable state in this arrhythmia.
We recently reported [4] a study of PBMV in 16 patients with mitral stenosis, all of whom had chronic atrial fibrillation and all of whom had been taking warfarin previously, which was stopped and restarted in a consistent manner. We found a significant increase in plasma levels of soluble P-selectin, an index of platelet activation, immediately post-PBMV and at 24 h, which was also associated with a significant increase in von Willebrand-factor levels, an index of endothelial damage\ dysfunction, at 24 h after PBMV. Our results therefore suggest an increase in platelet activation and endothelial damage\dysfunction following PBMV, and are consistent with the findings by Peverill et al. [1] of an increase in the venous F1j2 levels after PBMV. The findings from our study, and those of Peverill et al. [1] , suggest that changes may contribute to the increased risk of thromboembolism following PBMV and suggest the need for adequate antithrombotic therapy following this procedure.
Finally, the question of whether the abnormal coagulation state found in patients with mitral stenosis and atrial fibrillation is a localized or a generalized phenomenon is still unresolved. Based on patient cohorts who were in both atrial fibrillation and sinus rhythm, and differing antithrombotic regimes, the studies by Peverill et al. [5] and Yamamoto et al. [6] suggest that peripheral blood levels do not reflect intracardiac thrombogenesis. In our study [7] of 25 patients with mitral stenosis and atrial fibrillation, we did not find any significant variation in various indices of thrombogenesis (fibrin D-dimer), platelet activation (soluble P-selectin and β-thromboglobulin), endothelial dysfunction (von Willebrand factor and soluble thrombomodulin), and fibrinogen levels between the left atrium, right atrium and the peripheral artery or vein, suggesting that peripheral samples did reflect atrial coagulation, platelet and endothelial activities. The studies by Yasaka et al. [8] and Heppell et al. [9] also suggest that peripheral blood levels of haemostatic indices could be related to the presence of intracardiac thrombus.
We suggest that the process of thrombogenesis in cardiovascular disease is more likely to be a generalized process, rather than a highly localized one. Some caution is also needed with the use of markers such as F1j2, thrombin-antithrombin III complex and fibrinopeptide A [1, 5, 6] , since these markers are subject to errors (e.g. by activation during venipuncture [10] and, possibly, transseptal puncture during PBMV), and their prognostic value for thrombosis has yet to be established. Clearly, new insights into the prothrombotic or hypercoagulable state in cardiovascular disease are increasingly available, raising more questions and the need for answers [11] . Effects of balloon mitral valvuloplasty on systemic and regional left atrial levels of prothrombin fragment 1j2 in mitral stenosis:
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We thank Li-Saw-Hee and Lip for their interest in our paper and are pleased to respond to their comments regarding coagulation activity in mitral stenosis and, more specifically, aspects of our study hypothesis and design. Contrary to the assertion of Li-Saw-Hee and Lip that thrombogenesis in cardiac disease is likely to be a generalized process, we believe that there is now abundant evidence from our group [1] [2] [3] [4] and others [5] [6] [7] which supports the existence of a localized increase in left atrial coagulation activity in mitral stenosis. Moreover, this coagulation activation is not primarily due to atrial fibrillation as it is also observed in patients with sinus rhythm who have left atrial spontaneous echo contrast [1, 7] . The sole negative result in this area has been the recent study by Li-Saw-Hee et al. [8] , which found no difference in peripheral venous and left atrial levels of Ddimer and fibrinogen in patients with mitral stenosis, atrial fibrillation and no left atrial thrombus. However, as we pointed out in a letter which drew no response [9] , this study outcome was not surprising due to two features of the experimental design. First, D-dimer is not a direct or sensitive indicator of thrombin generation [9] , whereas fibrinogen is not even a marker of coagulation activation. Indeed, previous studies which have found elevated thrombin generation in the left atrium have not found an increase in the left atrial D-dimer level [1, 5, 7] . Secondly, patients had a mean international normalized ratio (INR) of 1.7 at the time of blood sampling, which is indicative of a persistent effect of preceding warfarin therapy. On available information [2] , even a minor prolongation of the INR to 1.2-1.4 in mitral stenosis suppresses increases in left atrial coagulation activity. A second issue raised by Li-Saw-Hee and Lip relates to changes in venous levels of coagulation markers in mitral stenosis and non-valvular atrial fibrillation, and the cause of such changes. There is considerable evidence that markers of thrombin generation [10] as well as fibrin generation and breakdown [10] [11] [12] are increased in venous blood samples in patients with documented left atrial thrombus, indicating that localized thrombus in the left atrium is associated with increases in levels of coagulation markers in the systemic cirulation. Unfortunately, interpretation of a number of previous studies which reported elevated peripheral venous levels of coagulation markers in mitral stenosis and non-valvular atrial fibrillation has been confounded by their failure to specifically exclude the diagnosis of left atrial thrombus with transoesophageal echocardiography [13] [14] [15] . Nonetheless, there is evidence that patients without left atrial thrombus, but with left atrial spontaneous echo contrast, have increased venous levels of thrombin-antithrombin complex [7] and fibrinopeptide A [16] on comparison with controls. In contrast, venous levels of F1j2 appear not to be elevated in such patients [1, 16, 17] , even when left atrial F1j2 levels are raised [1] . The basis of the apparent discrepancies between venous levels of F1j2 and other coagulation markers remains to be determined, as does the relative contribution to venous coagulation marker levels of changes in systemic coagulation activity per se versus spillover into the systemic circulation of coagulation markers formed in the left atrium [9] . While we agree with Li-Saw-Hee and Lip that the cause of increases in venous levels of coagulation markers in the absence of thrombus is incompletely understood, their association with left atrial spontaneous echo contrast in both mitral stenosis [17] and non-valvular atrial fibrillation [16] points strongly to a left atrial source for these increases.
Based on the ability of mitral valvuloplasty to improve flow in the left atrium and cause a reduction or resolution of left atrial spontaneous echo contrast [18] , the central hypothesis of our study was that balloon dilatation of the mitral valve would have a beneficial effect on increased left atrial coagulation activity [3] . Contrary to the contention of Li-Saw-Hee and Lip, no such benefit was anticipated (nor seen) in patients without an increase in left atrial coagulation activity prior to valvuloplasty. Moreover, in support of our notion that mitral valvuloplasty may produce differential coagulation changes in different patient subgroups, Zaki et al. [7] measured right and left atrial levels of thrombinantithrombin complex before and after valvuloplasty, and found a divergence between regional changes in this coagulation marker that was dependent on the extent of haemodynamic improvement occurring with the valvuloplasty procedure.
The question raised by Li-Saw-Hee and Lip of the possible effects of preceding warfarin therapy on coagulation activity is an important one, particularly given our prior observation that warfarin therapy suppressed increases in left atrial coagulation activity [2] . However, a feature of our study design was to only include patients without any prolongation of their INR at the beginning of the procedure [4] . While this does not completely exclude a residual effect of warfarin in our study, our previous finding of no difference in venous or left atrial F1j2 levels between patients who had or had not been on warfarin prior to the valvuloplasty procedure [1] , suggests that any such effect was likely to have been small. Furthermore, any minor suppression of coagulation activity by warfarin would have been present at the beginning of the procedure and does not explain the changes in F1j2 levels occurring after balloon mitral valvuloplasty [4] .
Based on the results of a study by Hafner et al. [19] , which assessed the effect of sampling methods on various coagulation markers, Li-Saw-Hee and Lip question our use of F1j2 and its ability to reliably measure thrombin generation. A major finding of the study of Hafner et al., however, was that F1j2 levels were not significantly influenced by blood sampling through central or peripheral catheters, which is also consistent with our previously published findings [1] .
Finally, while we share Li-Saw-Hee and Lip's interest in a longer term assessment of left atrial coagulation activity after valvuloplasty, clearly such a study would require a subsequent trans-septal puncture which would be neither practical nor ethical.
